Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Denali Therapeutics Inc.
Insider Chin Peter Scott of Denali Therapeutics Inc. filed a Form 4 on September 9, 2026, reporting changes in beneficial ownership as of September 4, 2026. This filing is a standard disclosure of insider equity transactions and does not involve any financial changes or new capital raising activities.…more
Denali Therapeutics Inc.
Insider Chin Peter Scott of Denali Therapeutics Inc. has filed an SEC Form 144 to report a proposed sale of company shares. This is a standard filing disclosing the insider's plan to dispose of their holdings.…more
Denali Therapeutics Inc.
Insider Nancy Thornberry of Denali Therapeutics Inc. filed a Form 4 report regarding a change in beneficial ownership of securities as of September 2, 2026.…more
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Denali Therapeutics to Report Q3 2026 Financial Results on Nov 3
Denali Therapeutics announced that it will release its financial results and business highlights for the third quarter of 2026 on November 3. The company will host a conference call to discuss the quarterly performance and provide a general business update.…more
●●●●●●●● ●●●●● ●●●●●●
데날리 테라퓨틱스가 오는 8월 6일 장 마감 후 2026년 2분기 실적 및 주요 사업 현황을 발표합니다. 이번 컨퍼런스 콜을 통해 회사의 최신 임상 진행 상황과 재무 성과가 공개될 예정입니다.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.